Company page

Hamlet Biopharma Ab Class B

Hamlet Biopharma Ab Class B, trading under the ticker HAMLET.B, is a public company based in Sweden with a market capitalization of approximately 116.8 million SEK. The company focuses on developing innovative cancer treatments. Its research aims to improve patient outcomes through targeted therapies.